Hydrocodone
- Generic Name
- Hydrocodone
- Brand Names
- Dalmacol, Hycet, Hycodan, Hydromet, Hysingla, Lorcet, Lortab, Norco, Obredon, Reprexain, Tussicaps, Tussionex, Vicoprofen, Xodol, Zamicet, Zohydro, Zydone
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO3
- CAS Number
- 125-29-1
- Unique Ingredient Identifier
- 6YKS4Y3WQ7
- Background
Hydrocodone is a synthetic opioid derivative of codeine. It is commonly used in combination with acetaminophen to control moderate to severe pain. Historically, hydrocodone has been used as a cough suppressant although this has largely been replaced by dextromethorphan in current cough and cold formulations. Hydrocodone's more potent metabolite, hydromorphon...
- Indication
Hydrocodone is indicated for the management of acute pain, sometimes in combination with acetaminophen or ibuprofen, as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.
- Associated Conditions
- Acute Pain, Chronic Pain, Cough, Cough caused by Allergic Rhinitis, Cough caused by Common Cold, Nasal Congestion caused by Allergic Rhinitis, Nasal Congestion caused by Common Cold, Rhinitis caused by Common Cold, Severe Pain, Moderate Pain, Upper respiratory symptoms caused by Allergic Rhinitis, Upper respiratory symptoms caused by Common Cold
- Associated Therapies
- -
Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments
- Conditions
- Interventions
- First Posted Date
- 2012-10-17
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- Ulthera, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT01708473
- Locations
- 🇺🇸
Dermatology, Cosmetic & Laser Surgery, Rockville, Maryland, United States
Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- NEMA Research, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01517295
- Locations
- 🇺🇸
NEMA Research Inc. (CRO), Naples, Florida, United States
🇺🇸International Clinical Research Institute, Leawood, Kansas, United States
Single Dose Pharmacokinetics of Egalet® Hydrocodone
- Conditions
- Interventions
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 28
- Registration Number
- NCT00802087
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.